TearClear Corp.

Pharmaceutical company · Princeton, New Jersey, United States

TearClear Corp. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

TearClear at a glance

Typepharmaceutical company
HeadquartersPrinceton, New Jersey, United States
Earliest incorporation on record2015
SEC CIK1706975

What does TearClear do?

Private fundraising reported to the SEC

10 Form D notices; the most recent reported $11.8 million sold (2023).

Frequently asked questions about TearClear

Where is TearClear headquartered?

TearClear Corp. is headquartered in Princeton, New Jersey, United States.

What does TearClear do?

TearClear Corp. is a pharmaceutical company.

When was TearClear founded?

The earliest incorporation on record for TearClear Corp. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences